Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | VP & Chief Accounting Officer | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,736 |
Ending reported balance
After 2026-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-11 · Grant · Acquired 490 · Balance 6,007 F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Row 2 · 2026-02-11 · Grant · Acquired 1,664 · Balance 7,671 F2: Represents the vesting of performance stock units (includes 29 dividend equivalent shares) for the 2023-2025 performance period. Row 3 · 2026-02-11 · Tax withholding · Disposed 865 · Balance 6,806 F3: 865 of the 1,664 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Row 4 · 2026-02-12 · Tax withholding · Disposed 70 · Balance 6,736 F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $178.68 · Expires 2036-02-11 | Direct | 1,800 |
Reported balance
After 2026-02-11 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-11 · Grant · Acquired 1,800 · Balance 1,800 F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 283 |
Reported balance
Holding disclosure · report date 2026-02-11 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 283 |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Represents the vesting of performance stock units (includes 29 dividend equivalent shares) for the 2023-2025 performance period.
F3: 865 of the 1,664 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2022 Filed Feb 14, 2022 13:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005082 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,455 F2 · shares: Acquired upon the settlement of performance shares granted on February 13, 2019 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 13:50 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005082 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,110 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| August 09, 2021 Filed Aug 9, 2021 21:29 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 10,520 | $132.02 | $1,388,850.40 |
DisclosureSEC source: 0001140361-21-027622 · form4.xml · nonDerivative · entry 4 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,502 F2 · price: Weighted average selling price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:29 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 12,248 | $134.04 | $1,641,721.92 |
DisclosureSEC source: 0001140361-21-027622 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,022 F2 · price: Weighted average selling price. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:29 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 10,170 | $60.85 | $618,844.50 |
DisclosureSEC source: 0001140361-21-027622 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 21:29 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 4,178 | $58.52 | $244,496.56 |
DisclosureSEC source: 0001140361-21-027622 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,300 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001140361-21-005107 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,928 Underlying: Common Stock · 2,300 shares Expires 2031-02-11 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 988 | $119.13 | $117,700.44 |
DisclosureSEC source: 0001140361-21-005107 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,947 F3 · shares: 988 of the 1,924 shares that vested February 11, 2021 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005107 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,935 F2 · shares: Acquired upon the settlement of performance shares granted on February 15, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 02:49 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-005107 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,011 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 11, 2021 Filed Mar 4, 2021 23:23 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 2,300 | $0.00 Strike: $119.13 | $0.00 |
DisclosureSEC source: 0001140361-21-007340 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,928 Underlying: Common Stock · 2,300 shares Expires 2031-02-11 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 11, 2021 Filed Mar 4, 2021 23:23 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 988 | $119.13 | $117,700.44 |
DisclosureSEC source: 0001140361-21-007340 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,797 F3 · shares: 988 of the 1,924 shares that vested February 11, 2021 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 11, 2021 Filed Mar 4, 2021 23:23 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-007340 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,785 F2 · shares: Acquired upon the settlement of performance shares granted on February 15, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
| February 11, 2021 Filed Mar 4, 2021 23:23 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-21-007340 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,861 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:22 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,200 | $0.00 Strike: $111.94 | $0.00 |
DisclosureSEC source: 0001140361-20-003556 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,628 Underlying: Common Stock · 3,200 shares Expires 2030-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:22 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 501 | $111.94 | $56,081.94 |
DisclosureSEC source: 0001140361-20-003556 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,211 F3 · shares: 501 of the 922 shares that vested February 13, 2020 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:22 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 922 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003556 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,712 F2 · shares: Acquired upon the settlement of performance shares granted on February 21, 2017 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:22 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-20-003556 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,790 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 22:18 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 641 | $87.32 | $55,972.12 |
DisclosureSEC source: 0001140361-19-003560 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,927 F1 · shares: On February 19, 2015, Balchem Corporation (the "Company") granted 1,315 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Company and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement. On February 19, 2019, 641 of the 1,315 shares that vested February 19, 2019 were withheld to cover withholding taxes due upon vesting. F2 · balance_after: Beneficial Ownership reconciled to reflect this transaction and those reported on Form 4 filed on February 15, 2018. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:40 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,900 | $0.00 Strike: $84.09 | $0.00 |
DisclosureSEC source: 0001140361-19-003367 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,246 Underlying: Common Stock · 3,900 shares Expires 2029-02-12 F4 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:40 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 761 | $84.09 | $63,992.49 |
DisclosureSEC source: 0001140361-19-003367 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,074 F3 · shares: 750 of the 1,405 shares that vested February 13, 2019 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:40 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003367 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,835 F2 · shares: Acquired upon the settlement of performance shares granted on February 22, 2016 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:40 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 3,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-19-003367 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,408 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 15:57 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 2,449 | $98.94 | $242,304.06 |
DisclosureSEC source: 0001140361-18-029248 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,953 F2 · shares: On June 19, 2014, the Company granted 5,000 restricted shares under the Company's Long-Term Incentive Program. The shares were subject to certain restrictions under the Restricted Stock Grant Agreement. On June 19, 2018, 2,449 of the shares that vested on June 19, 2018 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 15:57 UTC | BALCHEM CORP BCPC · Entity 3839 | OtherCommon Stock | 4,364 | $100.50 | $438,582.00 |
DisclosureSEC source: 0001140361-18-029248 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 14,402 F1 · kind: Intra-plan transfer from the Balchem Common Stock Fund to another fund within the respective plan. F1 · shares: Intra-plan transfer from the Balchem Common Stock Fund to another fund within the respective plan. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 13:36 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 490 | $76.21 | $37,342.90 |
DisclosureSEC source: 0001140361-18-010682 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,712 F1 · shares: On February 26, 2013, Balchem Corporation (the "Company") granted 1,000 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Company and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement on February 26, 2018. 490 of the 1,000 shares that vested February 26, 2018 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:57 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 3,650 | $0.00 Strike: $74.57 | $0.00 |
DisclosureSEC source: 0001140361-18-009173 · form4.xml · derivative · entry 4 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2028-02-15 F4 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:57 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 1,345 | $74.57 | $100,296.65 |
DisclosureSEC source: 0001140361-18-009173 · form4.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,202 F3 · shares: 1,345 of the 2,643 shares that vested February 15, 2018 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:57 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 2,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009173 · form4.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,547 F2 · shares: Acquired upon the settlement of performance shares granted on February 19, 2018 based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period under the Company's Second Amended and Restated 1999 Stock Plan (as amended and restated effective June 20, 2013) as a result of the satisfaction of those performance criteria. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:57 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009173 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,904 F1 · shares: Ownership of the restricted stock does not vest in Reporting person until four years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 21:49 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 48,500 | $83.60 | $4,054,469.05 |
DisclosureSEC source: 0001140361-17-011802 · doc1.xml · nonDerivative · entry 6 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,775 Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 21:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 15,000 | $50.32 | $754,800.00 |
DisclosureSEC source: 0001140361-17-011802 · doc1.xml · nonDerivative · entry 5 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 21:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 14,000 | $38.10 | $533,400.00 |
DisclosureSEC source: 0001140361-17-011802 · doc1.xml · nonDerivative · entry 4 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 21:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 2,500 | $31.02 | $77,550.00 |
DisclosureSEC source: 0001140361-17-011802 · doc1.xml · nonDerivative · entry 3 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 21:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 12,000 | $29.06 | $348,720.00 |
DisclosureSEC source: 0001140361-17-011802 · doc1.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| March 13, 2017 Filed Mar 13, 2017 21:49 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 5,000 | $40.95 | $204,750.00 |
DisclosureSEC source: 0001140361-17-011802 · doc1.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| March 03, 2017 Filed Mar 3, 2017 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 14,000 | $86.88 | $1,216,250.00 |
DisclosureSEC source: 0001140361-17-010546 · doc1.xml · nonDerivative · entry 2 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,775 Read SEC document |
| March 03, 2017 Filed Mar 3, 2017 21:37 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 14,000 | $32.21 | $450,940.00 |
DisclosureSEC source: 0001140361-17-010546 · doc1.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of a non-qualified stock option which fully vested on December 6, 2013. Read SEC document |
| February 21, 2017 Filed Feb 24, 2017 01:26 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantEmployee Stock Option (right to buy) · Derivative | 5,480 | $0.00 Strike: $85.40 | $0.00 |
DisclosureSEC source: 0001140361-17-008930 · doc1.xml · derivative · entry 1 Backus William A. · CIK 0001530884 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Stock · 0 shares Expires 2027-02-21 F1 · derivative.exercise_date: Options vest 20% year 1; 40% year 2; and 40% year 3. Read SEC document |
| February 29, 2016 Filed Feb 23, 2017 15:40 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 794 | $85.40 | $67,807.60 |
DisclosureSEC source: 0001140361-17-008734 · doc1.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,775 F1 · shares: On February 19, 2013, the Company granted 1,447 restricted shares under the Company's Management Long Term Incentive Program. The stock was subject to a repurchase option in favor of the Issuer and to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement on February 19, 2017. 794 of the 1,447 shares that vested February 19, 2017 were withheld to cover withholding taxes due upon vesting. F2 · balance_after: This filing amends the "amount of Securities Beneficially Owned Following Reported Transaction" to include the most current amount of shares owned directly by Mr. Backus in his 401(k)/profit sharing account. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.